GLP-1 medications such as Ozempic, Wegovy, and Mounjaro are changing the healthcare landscape and reshaping the food industry. As more U.S. adults use these medications for obesity, weight management, and diabetes treatment, manufacturers, retailers, restaurants, and ingredient suppliers are seeing measurable shifts in purchasing behavior.
The GLP-1 effects on food sales are already influencing everything from grocery store product mixes to restaurant menus and ingredient demand. While overall food consumption isn’t disappearing, consumers are buying different products, eating smaller portions, and placing greater emphasis on protein, fiber, and nutrient density.
For food manufacturers, these changing habits present both challenges and opportunities.
Key Takeaways
- GLP-1 medications are changing consumer purchasing behavior by reducing overall food consumption and shifting demand toward protein- and fiber-rich foods.
- Grocery stores, food manufacturers, and restaurants are adapting with new products, smaller portions, and GLP-1-friendly offerings.
- Demand for ingredients such as whey protein, milk proteins, and functional fibers is increasing as brands reformulate products.
What Are GLP-1 Medications?
GLP-1 receptor agonists, such as Ozempic, Wegovy, and Mounjaro, are medications originally developed to help manage type 2 diabetes. They work by mimicking glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that regulates blood sugar while slowing stomach emptying and increasing feelings of fullness.
As a result, many users consume fewer calories and report reduced cravings for high-fat, high-sugar foods. While not everyone experiences the same results, widespread adoption has created what many analysts now call the “Ozempic effect,” or, a measurable shift in food purchasing behavior.
Is Ozempic Affecting Food Sales?
Evidence increasingly suggests that it is. One study from the University of Arkansas Division of Agriculture found that the adoption of GLP-1 agonists changes both the amount and types of food people eat, which ultimately can impact food sales around certain foods and beverages. The study also determined that if GLP-1 adoption continues to increase, food companies will likely be challenged with a lower demand for processed foods.
Another study from the Journal of Marketing Research found that households using GLP-1 medications spent 5.3% less on groceries within six months of adoption and approximately 8% less at fast-food and limited-service restaurants. Researchers found the largest reductions in purchases of calorie-dense, processed foods, highlighting how GLP-1 medications are reshaping consumer purchasing behavior across the food industry.
Rather than eliminating demand for food, GLP-1 medications are changing what consumers value. With many people who use GLP-1 eating fewer calories, manufacturers and retailers have an opportunity to compete on quality, nutrition, convenience, and overall experience instead of portion size alone. This shift is driving innovation in high-protein, functional, and nutrient-dense products while encouraging companies to rethink how they meet changing consumer expectations.
The Rise of High-Protein Foods
One of the biggest GLP-1 effects on food sales has been the growing demand for protein-rich foods. Healthcare professionals frequently recommend that GLP-1 users prioritize protein intake to help preserve lean muscle mass during weight loss. As a result, consumers are increasingly seeking:
- Protein bars
- Ready-to-drink protein shakes
- Greek yogurt
- Cottage cheese
- High-protein frozen meals
- High-protein beverages
Groceries are also stocking meals and snacks with “GLP-1 friendly” labels to keep up with trending consumer preferences and maintain sales.
Restaurants Are Feeling the Impact
Restaurants may be experiencing some of the most noticeable changes, as frequent restaurant visitors who use GLP-1 medications may spend less per visit because they order fewer calorie-dense options.
However, many restaurant brands aren’t standing still. Major restaurant chains have adapted. Starbucks recently introduced a protein-focused beverage line as part of its evolving menu strategy, recognizing growing consumer demand for nutrient-dense options.
For manufacturers, this consumer behavior trend is increasing demand for ingredients such as:
- Milk protein concentrate
- Casein
- Plant proteins
- Fiber ingredients
- Functional sweeteners
What Does This Mean for Food Manufacturers?
The GLP-1 effects on food sales are accelerating broader shifts that were already underway. Food manufacturers and even beverage companies now have opportunities to innovate by developing new products that emphasize:
- Protein
- Fiber
- Functional nutrition
- Portion control
- Satiety
- Clean labels
At the same time, changing consumer demand may leave companies with excess inventories of ingredients tied to declining product categories. As product portfolios evolve, manufacturers may need to adjust purchasing strategies and manage obsolete ingredient inventories more proactively.
Looking Ahead
The long-term impact of GLP-1 medications on the food industry is still developing, but one trend is already clear: consumer expectations are changing.
Protein-forward products, functional ingredients, and nutrient-dense formulations are becoming increasingly important across grocery stores, restaurants, and food manufacturing. Companies that adapt their product portfolios and their ingredient sourcing strategies will be better positioned to meet changing consumer demand.
How Ingredient Exchange Helps Manufacturers Adapt
As the GLP-1 effects on food sales continue to reshape the marketplace, Ingredient Exchange remains committed to helping manufacturers source the ingredients they need today while navigating the supply chain challenges of tomorrow.
Ingredient Exchange helps manufacturers source ingredients that support today’s product innovations, including:
- Whey powders and protein
- Milk protein concentrates
- Casein
- Functional fibers
- Dairy ingredients
- Specialty food ingredients
Whether you’re scaling production of high-protein products or managing excess inventory from declining categories, our ingredient sourcing and inventory management services help manufacturers remain agile in a rapidly evolving marketplace.
FAQs
How does GLP-1 affect the food industry?
GLP-1 medications are reshaping the food industry by changing how consumers shop and eat. Many users report eating smaller portions, purchasing fewer indulgent foods, and prioritizing products that are higher in protein, fiber, and overall nutritional value. These shifts are influencing product development, ingredient demand, and retail merchandising strategies.
How has the rise of GLP-1 medications impacted grocery store sales?
The rise of GLP-1 medications has encouraged grocery retailers to expand assortments of high-protein foods, functional snacks, meal replacements, and portion-controlled products. Many manufacturers are also introducing products specifically marketed to GLP-1 users.
Which food categories are seeing the biggest impact from GLP-1 medications?
Research suggests that calorie-dense snacks, sugary beverages, desserts, and other highly processed foods are seeing softer demand among GLP-1 users, while protein-rich foods, functional snacks, dairy products, and meal replacements are experiencing increased interest.
How do eating habits change after GLP-1 usage?
GLP-1 medications often reduce appetite, leading many users to eat smaller portions, snack less frequently, and consume fewer calorie-dense foods. At the same time, many healthcare providers recommend prioritizing protein and fiber to help maintain lean muscle mass and support overall nutrition during weight loss.
As these eating habits become more common, food manufacturers and retailers are responding with more high-protein, portion-controlled, and nutrient-dense products, creating new opportunities for ingredient innovation and sourcing.
How should food manufacturers respond to GLP-1 trends?
Manufacturers should evaluate product portfolios, monitor changing consumer preferences, and consider reformulating products with higher protein, added fiber, reduced sugar, and improved nutrient density. They should also review ingredient sourcing strategies to ensure a reliable supply of in-demand ingredients.